Is BeyondSpring (USA Stocks:BYSI) outlook still optimistic?

BYSI Stock  USD 3.02  0.03  0.98%   
As many of us are excited about biotechnology space, it is fair to concentrate on BeyondSpring within current market trends. While the market posted solid gains today, things may not be as exiting for BeyondSpring in the long run. The returns on investing in BeyondSpring and the market returns of the last few months appear not related. Fragile basic indicators of the company may also hint to signs of long-run losses for BeyondSpring stockholders. BeyondSpring is scheduled to announce its earnings today. The stock is in a buyout trend.
Published over a month ago
View all stories for BeyondSpring | View All Stories
This firm's average rating is Hold from 5 analysts. Do analysts base this consensus on technical analyses? We know that typical technical analysis utilizes price momentum, patterns, and trends looking at historical prices. It aims to identify signals based on BeyondSpring market sentiment investors' perception of the future value of BeyondSpring. Let us look at a few aspects of BeyondSpring technical analysis.
Using predictive technical analysis, we will analyze different prices and returns patterns and diagnose historical swings to determine the real value of BeyondSpring. In general, we focus on analyzing BeyondSpring stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build BeyondSpring's daily price indicators and compare them against related drivers such as momentum indicators and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of BeyondSpring's intrinsic value. In addition to deriving basic predictive indicators for BeyondSpring, we also check how macroeconomic factors affect BeyondSpring price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of BeyondSpring's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of BeyondSpring in the context of predictive analytics.
Please note, it is not enough to conduct a financial or market analysis of a single entity such as BeyondSpring. Your research has to be compared to or analyzed against BeyondSpring's peers to derive any actionable benefits. When done correctly, BeyondSpring's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in BeyondSpring.

How does BeyondSpring Stands against Peers?

Analyzing BeyondSpring competition or peers my help you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Try to analyze the advantages of investing in traded instruments related to BeyondSpring across multiple sectors and thematic ideas. A good competitive analysis can cover a lot of different areas. But what areas to choose depends on who you are. The more exhaustive you are in your analysis, the more effective your competitive analysis will be.
Check out BeyondSpring Competition Details

How does BeyondSpring utilize its cash?

To perform a cash flow analysis of BeyondSpring, investors first need to understand how to read the cash flow statement. A cash flow statement shows the amount of cash BeyondSpring is receiving and how much cash it distributes out in a given period. The BeyondSpring cash flow statement breaks down these inflows and outflows into different buckets, including operating activities, investing activities, and financing activities.

Closer look at BeyondSpring Semi Deviation

BeyondSpring has current Semi Deviation of 4.2. Semi-deviation provides a good measure of downside risk for a equity or a portfolio. It is similar to standard deviation, but it only looks at periods where the returns are less than the target or average level.

Semi-deviation is the square root of semi-variance. Semi-variance is calculated by averaging the deviations of returns that have a result that is less than the mean.

Semi Deviation 
SQRT = Square root notation
SV =   BeyondSpring semi variance of returns over selected period
Let's now compare BeyondSpring Semi Deviation to its closest peers:

BeyondSpring technical analysis implies possible collapse

Current Information Ratio is up to 0.03. Price may drop again. BeyondSpring is displaying above-average volatility over the selected time horizon. Investors should scrutinize BeyondSpring independently to ensure intended market timing strategies are aligned with expectations about BeyondSpring volatility. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure BeyondSpring's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact BeyondSpring's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different stocks as prices fall.

Our Final Perspective on BeyondSpring

While some other entities under the biotechnology industry are still a bit expensive, BeyondSpring may offer a potential longer-term growth to stockholders. All things considered, as of the 16th of December 2022, we believe that at this point, BeyondSpring is very risky with low chance of financial distress within the next 2 years. From a slightly different point of view, the entity appears to be undervalued. However, our primary 90 days 'Buy-vs-Sell' recommendation on the company is Strong Sell.

Editorial Staff

This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Aina Ster do not own shares of BeyondSpring. Please refer to our Terms of Use for any information regarding our disclosure principles.

Would you like to provide feedback on the content of this article?

You can get in touch with us directly or send us a quick note via email to